期刊文献+

自然周期未成熟卵体外培养卵母细胞成熟率与临床结局的关系 被引量:2

Oocyte maturation rate of in vitro maturation treatment affects outcomes in vitro fertilization-embryo transfer
下载PDF
导出
摘要 目的探讨在自然周期未成熟卵体外培养后行体外受精与胚胎移植(IVF—ET),所获卵母细胞的成熟比例与胚胎发育及妊娠结局的关系。方法2008年1月至2011年4月接受自然周期未成熟卵体外培养治疗的PCOS患者183个周期,按卵母细胞成熟比例分为70%~100%(Ⅰ组)、55%~69%(Ⅲ组)、40%~54%(Ⅲ组)、〈40%(Ⅳ组),分析4组的胚胎发育情况及妊娠结局。结果4组的平均获卵数、受精率、卵裂率、平均胚胎移植数差异均无统计学意义(均P〉0.05)。Ⅳ组的胚胎种植率(7.14%)和妊娠率(13.51%)明显低于前3组(24.53%、22.93%、16.77%)和(48.65%、44.64%、33.96%),均P〈0.05,而其流产率(60%)则明显高于前3组(27.78%、20%、33.33%),均P〈0.05。结论卵母细胞成熟比例低组,胚胎的发育潜能及最终的妊娠结局也偏弱,流产率增加。 Objective To investigate the relationship between oocyte maturation rate and outcomes of in vitro fertiliza- tion-embryo transfer (IVF-ET). Methods A total of 183 cycles from patients with polycystic ovary syndrome (PCOS) underwent in vitro maturation treatment in our center from January 2008 to April 2011. According to the oocyte maturation rate the cycles were divided into 4 groups: group I (70%tol00%),group II (55%- 69%),group III (40%- 54%) and group IV (〈40%). Embryo development and pregnancy outcomes were compared among 4 groups. Results There were no significant differences in fertilization rate, cleavage rate ancl embryo transfer number among 4 groups. The embryo implantation rate and pregnancy rate in group IV (7.1%, 13.5%) was significantly lower than those of other 3 groups (24.5% and 48.7% in group I, 22.9% and 44.6% in group II, 16.8% and 34.0% in group III)(P〈0.05). The abortion rate in group IV (60.0%) was significantly higher than those of other 3 groups (27. 8% ,20.0% ,33.3% in group I,II,lll,respectively)(P〈0.05). Conclusion Low oocyte maturation rate might result in decreased embryo development potential, lower pregnancy rate and higher abortion rate in IVF-ET.
出处 《浙江医学》 CAS 2012年第17期1420-1423,共4页 Zhejiang Medical Journal
关键词 未成熟卵 体外培养 成熟比例 细胞核 胞质 Immature oocyte In vitro maturation Maturation rate Nucleus Cytoplasm
  • 相关文献

参考文献13

  • 1Chian R C, Buckett W M, Abdul Jalil A K,et al. Natural-cycle in vitro fertilization combined with in vitro maturation of immature oocytes is a potential approach in infertility treatmen[J]. Fertil Steril,2004, 82( 6 ): 1675-1678.
  • 2彭美莲,金帆,黄荷凤.人卵母细胞体外成熟培养研究进展[J].国外医学(计划生育.生殖健康分册),2006,25(1):22-24. 被引量:1
  • 3Jurema M W, Nogueira D. In vitro maturation of human oocytes for assisted reproduction [J]. Fertil Steril,2006,86(5):1277-1291.
  • 4Mikkelsen A L. In vitro maturation of human ova [C]. Intern Con- ger series,2004,1266: 160-166.
  • 5Picton H M,Briggs D,Gosden R G. The molecular basis of oocyte growth and development[J]. Mol Cell Endocrinol,1998, 145( 1-2 ):27-37.
  • 6Mikkelsen A L.Strategies in human in-vitro maturation and their clinical outcome[J].Reprod Biomed Online,2005,10( 5 ):593-599.
  • 7Son W Y, Lee S Y, Lira J H. Fertilization, cleavage and blastocyst development according to the maturation timing of oocytes in in- vitro maturation cycles[J].HumReprod,2005,20( 11 ): 3204-3207.
  • 8Balakier H, Sojecki A, Motamedi G, et aI,Time-dependent capa- bility of human oocytes for activation and pronuelear formation during metaphase II arrest[J].Hum Reprod,2004,19( 4):982-987.
  • 9Trouson A, Anderiesz C, Jones G. Maturation of human oocytes in vitro and their developmental competence[J]. Reproduction, 2001,121( 1 ):51-75.
  • 10Rodrigues B A, dos Santos L C, Rodrigues J L.Effect of matu- ration medium on in vitro cleavage of canine oocytes fertilized with fresh and cooled homologous semen [J].Zygote,2007,15 ( 1 ):43-53.

二级参考文献38

  • 1钱云,刘嘉茵,冯婷,陈娟,蔡令波,冒韵东,丁卫,张燕.未成熟卵体外成熟技术在卵巢反应不良和卵泡发育迟缓周期中的应用[J].中国实用妇科与产科杂志,2005,21(4):217-219. 被引量:6
  • 2李莉,丛林,曹云霞,章志国,魏兆莲,周平,赵济华,李芬.体外受精周期中卵泡发育阻滞患者应用未成熟卵体外成熟培养的临床观察[J].生殖医学杂志,2007,16(2):96-100. 被引量:2
  • 3[1]Kaai EM, Sasano H, Suzuki T, et al.Distribution of steroidogenic enzymes involved in androgen synthesis in polycystic ovaries: an immunohistochemical study.Mol Hum Reprod,2000,6:443~447.
  • 4[2]Pirwany IR, Yates RW, Cameron IT, et al.Effects of the insulin sensitizing drag metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea.Hum Reprod, 1999,14:2963~2968.
  • 5[3]Tropeano G,Liberale I, Vuolo IP, et al.Effects of ovary suppression by a long-acting GnRH-agonist on circulating GH, insulin-like growth factor I and insulin levels in women with polycystic ovary syndrome.J Endocrinol Invest,1997,20(4):220~224.
  • 6[4]Young RH.Dusting off old books: comments on classic gynecologic pathology books of yesteryear.Int J Gynecol Pathol, 2000, 19:6~84.
  • 7[5]Ferraretti AP, Gianaroli L, Magli MC, et al.Transvagifial ovarian drilling: a new surgical treatment for improving the clinical outcome of assisted reproductive technologies in patients with polycystic ovary syndrome.Fertil Steril, 2001,76:812~816.
  • 8Lim KS,Son WY,Yoon SH,et al.IVM-ET in stimulated cycles for the prevention of OHSS[J].Fertil Steril,2002(Supple 3s):S11-25.
  • 9Tsuji K,Sowa M,Nakano R.Relationship between human oocyte maturation and different follicular sizes[J].Biol Reprod,1985,32(2):413-417.
  • 10Antonio R,Fernando N,Marina A,et al.The potential use of maturation in vitro of human oocyte in low responder patients[J].JAFG,2000,17(5):239-244.

共引文献24

同被引文献12

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部